NEWS & ARTICLES - Ondine Biomedical

NEWS & ARTICLESWeb Master2026-05-25T13:58:31-07:00

News

Ondine Biomedical Leverages Mela Solutions’ 90% NHS ICU Footprint to Advance Commercial Evaluation and Quantify Steriwave® Financial Impact

Top Categories

Five Southern Ontario Hospitals to Deploy Steriwave® Across Approximately 5,000 Annual Surgical Procedures
September 23, 2026
Hospitales Ángeles Health System Pilots Steriwave® Nasal Photodisinfection in two flagship Mexican Hospitals
September 21, 2026
Ondine Biomedical Presents Topline Results from Phase 3 LANTERN Trial
September 10, 2026
Ondine Biomedical Announces Positive Topline Results from Phase 3 Pivotal LANTERN Study
September 1, 2026
Major Scottish Hospital Adopts Steriwave
July 30, 2026
Leeds drops SSI 78% over Mupirocin with Steriwave
June 30, 2026
Nasal Photodisinfection Reduces Surgical Infections in Complex Brain Surgery by 78.5% Compared to Nasal Antibiotics at Leeds Teaching Hospitals
June 18, 2026
Steriwave ICU Study Outcomes Presented at CSRT2026
May 26, 2026
Ondine Presented Steriwave Data at IPC 2026
April 30, 2026

For Media Information

5654 & Company

+44 (0) 0791 7800 011
+44 (0) 0775 7697 357
ondinebiomedical@5654.co.uk